EASL Studio – S3E9 – JHEP Live: ASOs vs siRNAs for treating chronic HBV: Who will be the winner?
In this JHEP Live: Antisense oligonucleotides vs. siRNAs in the treatment of chronic hepatitis B: Who will be the winner, if at all?, the faculty will be discussing the use of antisense oligonucleotides and siRNAs in the treatment of chronic hepatitis B infections.
Faculty: Prof. Joerg Petersen (Moderator), Prof. Maria Buti (Faculty), Prof. Man-Fung Yuen (Faculty)
Видео EASL Studio – S3E9 – JHEP Live: ASOs vs siRNAs for treating chronic HBV: Who will be the winner? автора Lifes Mysteries Revealed
Видео EASL Studio – S3E9 – JHEP Live: ASOs vs siRNAs for treating chronic HBV: Who will be the winner? автора Lifes Mysteries Revealed
Информация
3 ноября 2024 г. 11:51:31
00:36:56
Похожие видео



















